The novel highly transmissible human coronavirus SARS-CoV-2 is the causative agent of the
COVID-19 pandemic. Thus far, there is no approved therapeutic drug specifically targeting …

Recombinant Chinese hamster ovary (CHO) cells selected for high productivity are capable
of secreting immunoglobulin G (IgG) molecules at a level that rivals plasma cells in vivo. …

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), exhibits high levels of mortality and morbidity and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) global pandemic. The first step of viral infection is cell …

Public health experts emphasize the need for quick, point-of-care SARS-CoV-2 detection as
an effective strategy for controlling virus spread. To this end, many “antigen” detection …

Neutralizing antibodies represent a valuable therapeutic approach to countermeasure the
current COVID-19 pandemic. Emergence of SARS-CoV-2 variants emphasizes the notion that …

Monoclonal antibodies represent an important avenue for COVID-19 therapy and are routinely
used for rapid and accessible diagnosis of SARS-CoV-2 infection. The recent emergence …

Ricin, derived from the castor bean plant Ricinus communis, is one of the most potent and
lethal toxins known, against which there is no available antidote. To date, the use of …

Protective antigen (PA)-based vaccination is an effective countermeasure to anthrax infection.
While neutralizing anti-PA antibody titers elicited by this vaccine serve as good correlates …

The eradication of smallpox was officially declared by the WHO in 1980, leading to
discontinuation of the vaccination campaign against the virus. Consequently, immunity against …